Biotech · Private company
Raziel Therapeutics Ltd.
Track this companyFree. Adds Raziel Therapeutics Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials90 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- RZL-012Phase 2 · Flank MassClinicalTrials.gov · fetched Nov 12, 2026
- RZL-012Phase 2 · Submental FatClinicalTrials.gov · fetched Nov 12, 2026
- RZL-012Phase 2 · ObesityClinicalTrials.gov · fetched Nov 12, 2026
- RZL-012Phase 2 · LipedemaClinicalTrials.gov · fetched Nov 12, 2026
- RZL-012Phase 2 · Dercum's Disease LipomasClinicalTrials.gov · fetched Nov 12, 2026
- RZL-012+Celecoxib+ZyrtecPhase 2 · Submental FatClinicalTrials.gov · fetched Nov 12, 2026
- RZL-012+facial and neck wrapPhase 2 · Submental FatClinicalTrials.gov · fetched Nov 12, 2026
- RZL-012+Lidacaine injection prior treatmentPhase 2 · Submental FatClinicalTrials.gov · fetched Nov 12, 2026
- RZL-012+MedrolPhase 2 · Submental FatClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Dercum's Disease LipomasClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- An Open-label Study That Will Test a Second Treatment Session of RZL-012.PHASE2 · COMPLETED · started May 29, 2023ClinicalTrials.gov NCT05763160 · fetched Nov 12, 2026
- Evaluation the Effects of Various Treatments on RZL-012-Induced Adverse EventsPHASE1_PHASE2 · COMPLETED · started Sep 25, 2022ClinicalTrials.gov NCT05476679 · fetched Nov 12, 2026
- An Open Label Study That Will Test Safety and Efficacy of RZL-012 Injection Into the Submental Fat in Chinese vs. Non-Chinese Subjects.PHASE1_PHASE2 · COMPLETED · started Jul 29, 2022ClinicalTrials.gov NCT05466448 · fetched Nov 12, 2026
- Evaluation of Safety and Efficacy of RZL-012 in Subjects Seeking Fat Reduction in the FlanksPHASE2 · COMPLETED · started Mar 10, 2022ClinicalTrials.gov NCT05445557 · fetched Nov 12, 2026
- Efficacy and Safety of RZL-012 on Submental Fat ReductionPHASE2 · COMPLETED · started Jun 15, 2021ClinicalTrials.gov NCT04867434 · fetched Nov 12, 2026
- RZL-012 for Dercum's Disease LipomasPHASE2 · COMPLETED · started Jul 30, 2020ClinicalTrials.gov NCT04229030 · fetched Nov 12, 2026
- A Single Blind, Randomized, Placebo-controlled, Phase 2a, 2-cohort Study for the Evaluation of Safety and Efficacy of RZL-012 for Submental Fat Reduction in Healthy Volunteers.PHASE2 · COMPLETED · started Feb 25, 2020ClinicalTrials.gov NCT04086823 · fetched Nov 12, 2026
- Treatment of Women With Lipedema Involving Substantial Fat Knee of Women and Men With Nodular Dercum's DiseasePHASE2 · COMPLETED · started Jun 28, 2018ClinicalTrials.gov NCT03492840 · fetched Nov 12, 2026
- Evaluation of Safety, Efficacy and Thermogenesis-induction of RZL-012 in Overweight and Obese VolunteersPHASE2 · COMPLETED · started Jul 25, 2017ClinicalTrials.gov NCT03171415 · fetched Nov 12, 2026